###begin article-title 0
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquilin</italic>
###xml 84 94 84 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Role of X11 and ubiquilin as In Vivo Regulators of the Amyloid Precursor Protein in Drosophila
###end article-title 0
###begin p 1
Conceived and designed the experiments: MG GG RF AG. Performed the experiments: MG GG RF AG. Analyzed the data: MG GG RF AG. Contributed reagents/materials/analysis tools: JW HY. Wrote the paper: MG.
###end p 1
###begin p 2
Current address: Gevo Inc., Englewood, Colorado, United States of America
###end p 2
###begin p 3
###xml 17 25 <span type="species:ncbi:9606">Children</span>
Current address: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America
###end p 3
###begin p 4
Current address: Rainbow Transgenic Flies Inc., Newbury Park, California, United States of America
###end p 4
###begin p 5
###xml 747 751 726 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 756 772 735 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquilin (ubqn)</italic>
###xml 825 829 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 831 839 810 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11/Mint</italic>
###xml 845 849 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubqn</italic>
###xml 851 857 830 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 964 968 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 978 981 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 1104 1108 1075 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1118 1121 1089 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 1293 1297 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 1378 1382 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 802 807 <span type="species:ncbi:9606">Human</span>
###xml 972 977 <span type="species:ncbi:9606">human</span>
###xml 1112 1117 <span type="species:ncbi:9606">human</span>
###xml 1785 1800 <span type="species:ncbi:10090">transgenic mice</span>
The Amyloid Precursor Protein (APP) undergoes sequential proteolytic cleavages through the action of beta- and gamma-secretase, which result in the generation of toxic beta-amyloid (Abeta) peptides and a C-terminal fragment consisting of the intracellular domain of APP (AICD). Mutations leading to increased APP levels or alterations in APP cleavage cause familial Alzheimer's disease (AD). Thus, identification of factors that regulate APP steady state levels and/or APP cleavage by gamma-secretase is likely to provide insight into AD pathogenesis. Here, using transgenic flies that act as reporters for endogenous gamma-secretase activity and/or APP levels (GAMAREP), and for the APP intracellular domain (AICDREP), we identified mutations in X11L and ubiquilin (ubqn) as genetic modifiers of APP. Human homologs of both X11L (X11/Mint) and Ubqn (UBQLN1) have been implicated in AD pathogenesis. In contrast to previous reports, we show that overexpression of X11L or human X11 does not alter gamma-secretase cleavage of APP or Notch, another gamma-secretase substrate. Instead, expression of either X11L or human X11 regulates APP at the level of the AICD, and this activity requires the phosphotyrosine binding (PTB) domain of X11. In contrast, Ubqn regulates the levels of APP: loss of ubqn function leads to a decrease in the steady state levels of APP, while increased ubqn expression results in an increase in APP levels. Ubqn physically binds to APP, an interaction that depends on its ubiquitin-associated (UBA) domain, suggesting that direct physical interactions may underlie Ubqn-dependent regulation of APP. Together, our studies identify X11L and Ubqn as in vivo regulators of APP. Since increased expression of X11 attenuates Abeta production and/or secretion in APP transgenic mice, but does not act on gamma-secretase directly, X11 may represent an attractive therapeutic target for AD.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 327 334 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1A</xref>
###xml 643 646 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Selkoe1">[1]</xref>
###xml 797 804 766 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1A</xref>
###xml 1012 1015 963 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Selkoe1">[1]</xref>
One of the pathological hallmarks of Alzheimer's disease (AD) is the accumulation of amyloid plaques consisting of toxic beta-amyloid (Abeta) peptides. These peptides arise from the sequential cleavage of the Amyloid Precursor Protein (APP), a type I transmembrane protein, by two proteases known as beta- and gamma-secretase (Fig. 1A). APP proteolysis by beta-secretase generates an APP C-terminal fragment (CTF) known as C99. Subsequent cleavage of C99 by gamma-secretase results in the release of Abeta into the lumen and the APP intracellular domain (AICD) into the cytosol, where it can contribute to a transcriptional regulatory complex [1]. In addition to this amyloidogenic pathway, APP can also undergo non-amyloidogenic processing via sequential cleavage by alpha- and gamma- secretase (Fig. 1A). alpha-secretase cleaves within the Abeta sequence, thereby precluding the formation of Abeta. alpha-cleavage produces an APP CTF known as C83, which also serves as a substrate for gamma-secretase activity [1].
###end p 7
###begin title 8
Schematics depicting sites of APP cleavage and GAMAREP.
###end title 8
###begin p 9
###xml 365 369 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim</italic>
(A) The sequential actions of either alpha-secretase or beta-secretase, which cleaves APP in its extracellular domain, and gamma-secretase, which cleaves APP within its transmembrane domain, generate AICD and C83 or C99, respectively. alpha-secretase cleaves APP within the sequence of Abeta, thus precluding the generation of Abeta. (B) GAMAREP (GMR-C99-Gal4, UAS-grim) contains two components: First, C99-Gal4, a chimeric protein with an N-terminal cleavable signal sequence, transmembrane and intracellular domain (yellow bar) and a C-terminal Gal4 (blue circle) is specifically expressed in the eye and is a substrate for gamma-secretase. Second, Grim (purple bar) is expressed under the control of a Gal4-dependent promoter (green bar) as a readout. In the presence of endogenous gamma-secretase activity (scissor), the unleashed AICD-Gal4 (yellow bar and blue circle fragment) translocates to the nucleus (dashed curve) and binds to the UAS element and activates (black arrow pointing to the right) Grim expression. This leads to apoptosis in the eye, resulting in flies with small and rough eyes (red ovals depict relative eye size). (C) In the absence of gamma-cleavage, Gal4 remains tethered at the membrane and therefore is unable to activate Grim expression. This results in flies with increased eye size (i.e., suppression of GAMAREP phenotype). (D) When APP (C99) levels are downregulated, fewer substrate molecules are available (illustrated as one C99 molecule rather than three in B) to activate Grim-dependent apoptosis. This results in larger (suppressed) eye size. (E) When AICD is retained in the cytoplasm, or its levels or function are reduced (not illustrated here), apoptosis occurs less efficiently and the eyes remain large. (F) When AICD-Gal4 mediated transcription is inhibited, apoptosis is also reduced, resulting in flies with larger (suppressed) eyes. In summary, GAMAREP allows the identification of factors that regulate endogenous gamma-secretase activity (as in C), as well as factors that regulate APP steady state levels (as in D), and AICD function, stability and/or cytoplasmic retention (as in E and F). (G) The false positive reporter. Suppression of GAMAREP can also arise from factors that regulate processes other than APP biology, such as mutations modifying GMR- or Gal4-dependent transcriptional activation, or apoptosis, which we collectively named false positives. To eliminate these factors, we employed a "false positive" reporter (GMR-Gal4, UAS-apoptotic gene). True modifiers are those that modify they eye phenotypes of GAMAREP, but not those of the false positive reporter.
###end p 9
###begin p 10
###xml 124 127 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Edbauer1">[2]</xref>
###xml 129 132 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Iwatsubo1">[3]</xref>
###xml 213 216 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Goate1">[4]</xref>
###xml 217 220 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sherrington1">[7]</xref>
###xml 358 361 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-RoveletLecrux1">[8]</xref>
###xml 363 366 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Theuns1">[9]</xref>
###xml 673 677 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Cao1">[10]</xref>
###xml 801 805 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-PardossiPiquard1">[11]</xref>
###xml 806 810 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hamid1">[21]</xref>
gamma-secretase activity resides in a multi-protein complex that minimally contains Presenilins, Nicastrin, Aph-1 and Pen-2 [2], [3]. Mutations in APP, Presenilin 1 and Presenilin 2 cause familial, early onset AD [4]-[7]. In addition, the triplication of the APP locus as well as promoter mutations in APP that increase APP expression are associated with AD [8], [9]. The function of the AICD may also be crucial for AD pathogenesis, since each time Abeta is generated, AICD is simultaneously released. AICD, in conjunction with two PTB domain-containing proteins (Fe65 and Tip60), can enter the nucleus and regulate the transcription of target genes, including APP itself [10]. In addition, AICD has also been implicated in other processes including cell signaling, apoptosis and calcium homeostasis [11]-[21]. Therefore, identifying genes that regulate APP steady-state levels, APP cleavage, and the fate and activity of AICD are likely to further our understanding of AD pathogenesis.
###end p 10
###begin p 11
###xml 281 285 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Rogelj1">[22]</xref>
###xml 430 434 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-McLoughlin1">[23]</xref>
###xml 436 440 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Jacobs1">[24]</xref>
###xml 563 567 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg1">[25]</xref>
###xml 568 572 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sastre1">[27]</xref>
###xml 678 682 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee1">[28]</xref>
###xml 684 688 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee2">[29]</xref>
###xml 762 766 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg2">[30]</xref>
###xml 768 772 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-McLoughlin2">[31]</xref>
###xml 814 818 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Biederer1">[32]</xref>
###xml 903 911 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 916 923 871 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1015 1019 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg1">[25]</xref>
###xml 1021 1025 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sastre1">[27]</xref>
###xml 1027 1031 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King1">[33]</xref>
###xml 1033 1037 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Araki1">[34]</xref>
###xml 1106 1110 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lau1">[35]</xref>
###xml 1212 1216 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King2">[36]</xref>
###xml 1323 1327 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee2">[29]</xref>
###xml 580 595 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1288 1303 <span type="species:ncbi:10090">transgenic mice</span>
The X11/Mint protein family consists of three mammalian members: X11alpha and X11beta, which are expressed in neurons, and X11gamma which is ubiquitously expressed. All three X11 proteins contain a phosphotyrosine binding (PTB) domain, followed by two PSD95/Dlg/ZO-1 (PDZ) domains [22]. Several observations suggest links between X11 and AD. First, X11alpha and X11beta have been found in amyloid plaques in post-mortem AD brains [23], [24]. Second, increased X11alpha and X11beta expression in mammalian cells leads to a reduced secretion of extracellular Abeta [25]-[27], while transgenic mice expressing either X11alpha or X11beta are associated with reduced levels of Abeta [28], [29]. Third, X11 proteins physically interact with AICD via their PTB domains [30], [31] and inhibit AICD-dependent transcription [32]. Fourth, X11alpha and X11beta overexpression increases APP steady-state levels both in vitro and in vivo, likely due to altered maturation in the secretory pathway or endocytic trafficking of APP [25], [27], [33], [34]. Finally, the X11 proteins bind to presenilin via their PDZ domains [35]. Furthermore, X11alpha and X11beta have been reported to modulate gamma-secretase in mammalian cells [36]; however, alterations in the levels of C83 and C99 are not observed in transgenic mice overexpressing X11 [29]. These conflicting observations leave it unclear whether X11 overexpression can regulate gamma-secretase activity.
###end p 11
###begin p 12
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubiquilin 1 (UBQLN1)</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Mah1">[37]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Davidson1">[38]</xref>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Mah1">[37]</xref>
###xml 435 438 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Selkoe1">[1]</xref>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Blacker1">[39]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Myers1">[40]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Bertram1">[41]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Kamboh1">[42]</xref>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Slifer1">[43]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Bensemain1">[46]</xref>
###xml 700 706 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQ-8i</italic>
###xml 928 938 928 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 978 984 978 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQ-8i</italic>
###xml 1089 1095 1089 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 1095 1099 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 1133 1137 1133 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Mah1">[37]</xref>
###xml 1232 1236 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 1238 1253 1238 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila ubqn</italic>
###xml 1266 1276 1266 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">presenilin</italic>
###xml 1278 1281 1278 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 1407 1411 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 1413 1417 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Li1">[48]</xref>
###xml 1465 1471 1465 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 1551 1555 1548 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hiltunen1">[49]</xref>
###xml 1585 1591 1582 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UBQLN1</italic>
###xml 1637 1641 1634 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Li1">[48]</xref>
###xml 1642 1646 1639 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Zhang2">[50]</xref>
###xml 972 977 <span type="species:ncbi:9606">human</span>
###xml 1083 1088 <span type="species:ncbi:9606">human</span>
###xml 1187 1192 <span type="species:ncbi:9606">human</span>
Ubiquilin 1 (UBQLN1) is another gene that has been linked to AD. UBQLN1 encodes a protein with ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains, as well as Sti1 repeats [37], which are often associated with chaperone activity [38]. Several studies suggest links between UBQLN1 and AD. First, in post-mortem AD brains, UBQLN1 is found in neurofibrillary tangles [37], a pathological hallmark of AD along with amyloid plaques [1]. Second, the genomic region containing UBQLN1, 9q22, has been identified as containing one major candidate gene for conferring a predisposition to late onset AD [39], [40]. Some reports [41], [42], but not others [43]-[46], suggest that genetic variants in the UBQLN1 gene, including one known as UBQ-8i that deletes one Sti1 repeat, are associated with increased risk for the more prevalent late-onset forms of AD. Further evidence that UBQ-8i has enhanced toxicity comes from studies in Drosophila demonstrating that expression of human UBQ-8i in flies leads to earlier onset and more severe eye degeneration than does expression of wildtype human UBQLN1[47]. Third, UBQLN1 binds PS1 and PS2 [37], and the fly homolog of Presenilin binds to both human and fly Ubiquilin (Ubqn), respectively [47]. Drosophila ubqn antagonizes presenilin (psn) function in both loss-of-function and gain-of-function studies during development and adult-onset neurodegeneration in vivo [47], [48]. Finally, in cultured cells, downregulation of UBQLN1 expression alters APP levels and Abeta secretion by modulating APP trafficking [49]. However, reports of altered UBQLN1 expression on APP processing are conflicting [48]-[50]. Because increases in APP levels and/or altered APP processing are likely to be important risk factors for AD, it is crucial to clarify the effect of UBQLN1 on APP in an in vivo system. Additionally, since both X11 and UBQLN1 have been implicated as regulators of APP steady state levels and APP processing, it is crucial to assess the extent to which each molecule contributes to the myriad regulations of APP-related processes, and to determine what their net effect is in vivo.
###end p 12
###begin p 13
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Marsh1">[51]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Dodson1">[54]</xref>
###xml 127 137 127 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Luo1">[55]</xref>
###xml 223 227 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hu1">[56]</xref>
###xml 229 233 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Takasugi1">[57]</xref>
###xml 262 272 258 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 349 353 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Fossgreen1">[58]</xref>
###xml 355 359 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 472 476 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Greeve1">[60]</xref>
###xml 491 501 473 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 548 552 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Rogelj1">[22]</xref>
###xml 554 558 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hase1">[61]</xref>
###xml 620 624 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 626 630 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Li1">[48]</xref>
###xml 0 23 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 424 429 <span type="species:ncbi:9606">human</span>
Drosophila melanogaster is a useful model organism for studying neurodegenerative diseases and AD-related processes [51]-[54]. Drosophila contains homologs of APP [55] and all four components of the gamma-secretase complex [56], [57]. Expression of human APP in Drosophila results in its cleavage by endogenous alpha- and gamma-secretase activities [58], [59]. Furthermore, co-expression of human beta-secretase (BACE1) and human APP fully reconstitutes APP beta-cleavage [60]. In addition, Drosophila contains homologs of X11/Mint family proteins [22], [61] and UBQLN1 with evolutionarily conserved domain architecture [47], [48].
###end p 13
###begin p 14
###xml 100 104 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 106 114 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig 1B-F</xref>
###xml 148 152 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim</italic>
###xml 164 167 160 163 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gam</underline>
###xml 193 194 189 190 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 203 206 199 202 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rep</underline>
###xml 553 557 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim</italic>
###xml 557 561 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hay1">[62]</xref>
###xml 563 567 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hay2">[63]</xref>
###xml 625 632 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1B</xref>
###xml 732 736 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim</italic>
###xml 804 808 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 853 860 841 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1C</xref>
###xml 1318 1322 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 1402 1406 1378 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 1533 1540 1509 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1D</xref>
###xml 1608 1618 1584 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1E, F</xref>
###xml 1820 1827 1796 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g001">Fig. 1G</xref>
###xml 1999 2003 1975 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 2008 2012 1984 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 2037 2047 2013 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 357 362 <span type="species:ncbi:4932">yeast</span>
We engineered transgenic flies that act as living reporters for gamma-secretase activity in the eye [59] (Fig 1B-F). These flies (GMR-C99-Gal4, UAS-grim), known as gamma-secretase activity and APP level reporters (hereafter called GAMAREP), express a chimeric protein which contains a signal sequence, followed by a fusion of the C99 fragment of APP to the yeast transcription factor Gal4. This C99-Gal4 protein is expressed specifically in the developing eye in the presence of a Gal4 responsive element that drives an apoptosis-inducing gene known as grim[62], [63]. In the presence of endogenous gamma-secretase activity (Fig. 1B), AICD-Gal4 is liberated from the membrane, migrates to the nucleus and activates transcription of grim. The resulting apoptosis generates flies with small and rough eyes [59]. When gamma-secretase activity is impaired (Fig. 1C), Gal4 remains tethered to the membrane, resulting in less apoptosis. Therefore, the size and roughness of the eye inversely correlates, in a semi-quantitative manner, with the level of endogenous gamma-secretase activity (high levels of activity results in flies with small eyes while low levels are associated with nearly normal eyes). These flies act as sensitive reporters for modest changes (two-fold) in the levels of known gamma-secretase components [59]. Though originally intended to identify regulators of gamma-secretase activity [59], the eye phenotypes of GAMAREP flies are also expected to be sensitive to genetic perturbations that alter the levels of APP (Fig. 1D), AICD function, and/or the transcriptional activity of AICD-Gal4 (Fig. 1E, F). To discriminate factors that regulate transgene expression levels, Gal4-dependent transcriptional efficiency or apoptosis, we also generated a false positive reporter (GMR-Gal4, UAS-apoptotic gene) (Fig. 1G). True modifiers will be identified as factors that modify only GAMAREP eye phenotypes, and not those of the false positive reporter. Here we report the identification of X11L and ubqn as regulators of APP in Drosophila.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
Increased expression of X11L suppresses GAMAREP eye phenotypes
###end title 16
###begin p 17
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 540 547 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2A</xref>
###xml 618 622 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 687 694 687 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2E</xref>
###xml 747 754 747 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2F</xref>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 847 854 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002495.s001">Fig. S1</xref>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 1048 1055 1048 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2G</xref>
We carried out a genetic screen (to be described in detail elsewhere) in which GAMAREP flies were crossed with flies carrying single insertions of the EP P element on the X chromosome. EP elements carry a Gal4 responsive promoter pointing outwards from the end of the transposon. Thus, when inserted near the 5' end of a gene, EP elements can drive nearby gene overexpression in a Gal4 dependent manner. From this screen, we identified one suppressor line, which contains an EP element insertion in the 5' region of the X11L gene (CG5675) (Fig. 2A). To confirm that the GAMAREP suppression is due to overexpression of X11L, we showed that eye-specific overexpression of X11L (GMR-X11L) (Fig. 2E) indeed suppressed the GAMAREP small eye phenotype (Fig. 2F compared to C). X11L overexpression was confirmed using anti-X11L antibodies (Supplementary Fig. S1). Importantly, X11L overexpression had no effect on the small eye phenotypes of flies expressing apoptosis-inducing genes under the direct control of GMR-Gal4 (false positive reporters; [59]) (Fig. 2G compared to D), indicating that X11L acts specifically on C99, not on GAL4 or apoptotic genes.
###end p 17
###begin p 18
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 75 84 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;,</italic>
###xml 104 112 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 142 149 134 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2H</xref>
###xml 184 192 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 245 252 233 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2I</xref>
###xml 300 307 288 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2J</xref>
###xml 329 344 317 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila X11L</italic>
###xml 355 363 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 472 478 <span type="species:ncbi:9606">humans</span>
To demonstrate that the mechanism we uncovered for X11L is shared by human X11alpha, we expressed human X11alpha specifically in the fly eye (Fig. 2H). Strikingly, expression of human X11alpha also suppressed the small eye phenotype of GAMAREP (Fig. 2I), but not that of the false positive reporter (Fig. 2J). This suggests that Drosophila X11L and human X11alpha show functional conservation and that mechanisms of action discovered in flies are likely to be relevant to humans.
###end p 18
###begin title 19
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 36 44 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Overexpression of fly X11L or human X11alpha specifically suppresses GAMAREP.
###end title 19
###begin p 20
###xml 19 34 19 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila X11L</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 608 616 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 622 630 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 750 754 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 775 779 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 866 870 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 884 888 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1150 1161 1130 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim/reaper</italic>
###xml 1184 1188 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1273 1277 1249 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ashley1">[75]</xref>
###xml 1313 1317 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1342 1346 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1364 1368 1340 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1457 1461 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Vishnu1">[76]</xref>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 1058 1063 <span type="species:ncbi:9606">human</span>
(A) Genomic map of Drosophila X11L (CG5675, cytological location 16B7). The P element insertion (triangle), X11L coding and the untranslated regions (dark and shaded rectangles, respectively) are illustrated. X11L encodes a protein with a PTB and two PDZ domains that are conserved in human X11 proteins. (B-M) Scanning electron micrographs (SEM) of adult fly eyes of various genotypes. GAMAREP flies exhibit small, rough eyes (C) as compared to the wildtype (B). Overexpression of X11L (GMR-X11L) shows no external eye phenotypes (E), but strongly suppresses GAMAREP eye phenotypes (F). Expression of human X11alpha (GMR-X11alpha), which by itself does not produce any visible eye phenotypes (H), suppresses GAMAREP phenotypes as effectively as fly X11L overexpression (I). X11L's ability to suppress GAMAREP is dependent on its PTB domain, since overexpression of X11LDeltaPTB (GMR-X11LDeltaPTB) (K) fails to suppress GAMAREP eye phenotype (L). The ability of X11 to suppress GAMAREP eye phenotype is specific, since overexpression of X11L, X11DeltaPTB or human X11 fails to suppress the eye phenotype of the false-positive reporter (GMR-Gal4, UAS-grim/reaper) (D, G, J and M). The X11LDeltaPTB transgene expresses a truncated protein as detected by anti-X11L antibodies [75]. Of note, strong overexpression of X11L (multiple copies of GMR-X11L or GMR-Gal4, UAS-X11L) can result in a rough eye phenotype (data not shown), consistent with previous reports [76].
###end p 20
###begin title 21
X11L overexpression regulates APP at the level of AICD
###end title 21
###begin p 22
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 133 143 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 171 174 171 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sub>
###xml 344 351 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3A</xref>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3B</xref>
###xml 563 577 547 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3A and 3B</xref>
###xml 668 678 652 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 792 799 776 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2C</xref>
###xml 892 895 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 897 900 877 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nct</italic>
###xml 902 907 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aph-1</italic>
###xml 911 916 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pen-2</italic>
###xml 1025 1039 1001 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3A and 3B</xref>
###xml 1109 1114 1085 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D279A</sup>
###xml 1145 1150 1121 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D257A</sup>
###xml 1150 1154 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
###xml 1203 1216 1179 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3C and E</xref>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 1136 1141 <span type="species:ncbi:9606">human</span>
To determine how increased X11L expression regulates APP in the GAMAREP system, we established assays for APP levels and cleavage in Drosophila. Full length human APP (APP695) or C99 was myc-tagged at the C-terminus and expressed in the eye. Tissue lysates were examined by Western blotting with an anti-Myc antibody to follow the fate of APP (Fig. 3A) or C99 (Fig. 3B). APP-Myc or C99-Myc was cleaved by endogenous alpha- and gamma-secretase in both systems, yielding an AICD-Myc fragment (gamma-secretase cleaved) and C83 (an alpha-secretase cleaved fragment) (Fig. 3A and 3B). Furthermore, although no endogenous BACE activity has been definitively demonstrated in Drosophila, expression of human BACE in the presence of APP resulted in the generation of C99, in addition to C83 and AICD (Fig. 2C). RNAi-mediated silencing of any one of the four components of the gamma-secretase complex, psn, nct, aph-1 or pen-2, resulted in attenuated AICD generation and an increase in the levels of CTFs (gamma-secretase substrates) (Fig. 3A and 3B). In addition, overexpression of a dominant negative form of psn (PsnD279A which corresponds to human PS1D257A[59]) resulted in similar effects on APP processing (Fig. 3C and E).
###end p 22
###begin title 23
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
X11L overexpression does not alter APP levels or processing.
###end title 23
###begin p 24
###xml 726 728 706 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DN</sup>
###xml 870 874 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 885 893 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 1343 1345 1315 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DN</sup>
###xml 1438 1442 1410 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
(A-C, E) Western blotting of adult head lysates from various transgenic flies. (A) When APP-9Myc is expressed, the endogenous alpha- and gamma- secretase mediated cleavages generate C83 and AICD, respectively. RNAi knockdown of any one of the four components of the gamma-secretase complex results in reduction of AICD levels and an increase in the levels of C83, as compared with sibling controls. (B) When C99-9Myc is expressed, the endogenous gamma-cleavage generates AICD. RNAi knockdown of any one of the four gamma-secretase components results in a reduction in AICD levels and a simultaneous increase in levels of the CTFs. (C) Co-expression of human BACE and APP-9Myc generates C83, C99 and AICD. Overexpression of PsnDN results in a reduction of AICD and an increase in the levels of gamma-secretase substrates (C83 and C99). In contrast, expression of neither X11L nor human X11alpha results in any alteration in the CTF levels. (D) Western blot quantifications of APP and its fragments suggest that there are no significant differences in the levels of either full length APP or its fragments as compared to control. Values are normalized to the corresponding tubulin loading controls. Data from X11 overexpression (dark bars) and control (white bars) are analyzed by paired t-test. (E) When C99-9Myc is expressed, expression of PsnDN results in a decrease in AICD levels and an increase in C83 levels, while overexpression of X11L fails to show any changes. Note that panels depicting CTFs are from the same Western blots exposed for different lengths of time than the corresponding APP panels. For each sample, sibling flies of the appropriate genotype raised under identical conditions were used as controls, and are shown immediately adjacent to the corresponding experimental sample (linked by a horizontal bar).
###end p 24
###begin p 25
###xml 132 136 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lau1">[35]</xref>
###xml 150 160 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 272 276 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 421 424 409 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 426 441 414 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nicastrin (nct)</italic>
###xml 443 448 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aph-1</italic>
###xml 452 457 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pen-2</italic>
###xml 537 550 525 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3C and D</xref>
###xml 585 589 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 694 701 678 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g003">Fig. 3E</xref>
###xml 757 761 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 6 11 <span type="species:ncbi:9606">human</span>
Since human X11alpha has previously been shown to bind Presenilin and regulate gamma-secretase-mediated cleavage in mammalian cells [35], we asked if Drosophila X11L overexpression suppressed GAMAREP by inhibiting gamma-secretase activity. We crossed flies overexpressing X11L with flies expressing APP-Myc, and their progeny were subjected to Western blot analysis. In contrast to what was observed for the knockdown of psn, nicastrin (nct), aph-1 or pen-2 function, we did not see any reduction in AICD levels or any CTF accumulation (Fig. 3C and D). Similarly, flies overexpressing X11L in the background of C99-Myc expression also failed to show any evidence of gamma-secretase inhibition (Fig. 3E). These results suggest that the predominant effect of X11L overexpression in vivo is not due to gamma-secretase inhibition.
###end p 25
###begin p 26
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg1">[25]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sastre1">[27]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King1">[33]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Araki1">[34]</xref>
With increased expression of X11L (multiple copies of transgenes), we observed a slight increase in the steady-state levels of APP (data not shown), which is consistent with reported findings in mammals [25], [27], [33], [34]. However, full-length APP and its proteolytic fragments increased largely in proportion. The slight increase in levels of AICD is likely to be physiologically inconsequential, since elevated levels of AICD are predicted to enhance the GAMAREP eye phenotype, whereas we observed a robust suppression.
###end p 26
###begin p 27
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 273 276 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 289 303 285 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4A and 4E</xref>
###xml 454 458 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Hay1">[62]</xref>
###xml 459 463 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Yoo1">[64]</xref>
###xml 479 486 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4E</xref>
###xml 544 551 540 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2C</xref>
###xml 815 824 807 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4B&#8211;D</xref>
###xml 857 861 849 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 942 949 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4F</xref>
###xml 991 995 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1099 1107 1087 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 1167 1171 1151 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1173 1180 1157 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4H</xref>
###xml 1226 1236 1210 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1247 1250 1231 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 1093 1098 <span type="species:ncbi:9606">human</span>
###xml 1241 1246 <span type="species:ncbi:9606">human</span>
To explore if X11L overexpression regulates AICD function independently of gamma-secretase regulation, we generated transgenic flies that overexpressed a fusion protein of the AICD and Gal4 specifically in the eye (GMR-AICD-Gal4). Flies carrying both GMR-AICD-Gal4 and UAS-hid transgenes (Fig. 4A and 4E, hereafter called the AICDREP) were viable but exhibited an almost complete absence of eye tissue, due to extensive apoptosis of the cells in the eye [62]-[64]. This AICDREP (Fig. 4E) displayed a much smaller eye size than that of GAMAREP (Fig. 2C), presumably because in the AICDREP, Gal4 is not tethered to the membrane as compared to C99-Gal4, and therefore does not require any liberation by gamma-secretase. The AICDREP thus serves as a useful system to identify genes that regulate AICD function in vivo (Fig. 4B-D). Remarkably, overexpression of X11L in the presence of AICDREP almost completely restored the eye size to wildtype (Fig. 4F). This suggests that the major effect of X11L overexpression is the gamma-secretase independent inhibition of AICD. In addition, expression of human X11alpha suppressed the AICDREP as effectively as overexpression of X11L (Fig. 4H), indicating functional conservation between Drosophila and human X11.
###end p 27
###begin title 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
X11L overexpression suppresses the AICDREP.
###end title 28
###begin p 29
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 906 910 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1284 1287 1268 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 1094 1099 <span type="species:ncbi:9606">human</span>
###xml 1218 1223 <span type="species:ncbi:9606">human</span>
(A-D) Schematic illustration of the AICDREP. (A) AICDREP (GMR-AICD-Gal4, UAS-hid) is composed of two transgenic components. One expresses a fusion protein (AICD-Gal4) (yellow bar connected to blue circle) specifically in the eye. The other expresses the apoptotic gene hid (yellow bar) under the control of the UAS promoter (green bar). The AICDREP flies exhibit almost no eye, due to extensive apoptosis. The AICDREP serves as a useful system to identify genes that regulate AICD levels (B), transcriptional activity (C), as well as AICD cytoplasmic retention (D) in vivo. False positive modifiers such as factors regulating the expression levels of transgenes, Gal4's ability to activate transcription, or apoptosis can be excluded using GMR-Gal4, UAS-hid (I). (E-L) SEMs of adult fly eye of various genotypes. (E) The AICD reporter flies exhibit an almost total lack of ommatidia. (F) Overexpression of X11L results in a dramatic suppression of the AICDREP and restores the eye to nearly wildtype. (G) Overexpression of X11DeltaPTB fails to suppress the AICDREP phenotype. (H) Expression of human X11alpha also demonstrates dramatic rescue of the AICDREP eye phenotype. (I-L) Overexpression of X11L, X11DeltaPTB or human X11alpha does not affect the eye phenotype of GMR-Gal4, UAS-hid transgene. (M) Western Blotting of adult head lysates. Neither X11L overexpression nor X11alpha expression alters AICD levels. Each experimental and its relevant control samples are linked by a horizontal line.
###end p 29
###begin p 30
###xml 73 77 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg2">[30]</xref>
###xml 79 83 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-McLoughlin2">[31]</xref>
###xml 356 363 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2K</xref>
###xml 414 421 402 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2L</xref>
###xml 426 428 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">4G</xref>
###xml 604 607 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 625 634 605 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4I-L</xref>
###xml 784 791 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g004">Fig. 4M</xref>
###xml 562 567 <span type="species:ncbi:9606">human</span>
Mammalian X11alpha has been shown to bind to the AICD via its PTB domain [30], [31]. If X11L overexpression exerts its major effect on AICD, we would expect that expression of a truncated X11L lacking its PTB domain (X11LDeltaPTB) should no longer be able to suppress the GAMAREP or AICDREP phenotypes. Indeed, eye-specific overexpression of X11LDeltaPTB (Fig. 2K) failed to suppress both GAMAREP and the AICDREP (Fig. 2L and 4G), further supporting the hypothesis that X11L regulates AICD function. Importantly, neither overexpression of X11L, X11LDeltaPTB nor human X11alpha affected the GMR-Gal4, UAS-hid)\ eye phenotype (Fig. 4I-L), suggesting that X11 expression acts specifically on AICD. Furthermore, the expression of X11L or X11alpha did not affect AICD steady-state levels (Fig. 4M), suggesting that X11 may promote cytoplasmic retention of AICD, or inhibit its ability to regulate transcription.
###end p 30
###begin title 31
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
X11L overexpression does not affect the gamma-secretase mediated cleavage of Notch
###end title 31
###begin p 32
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 153 157 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King2">[36]</xref>
###xml 207 211 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 419 423 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-ArtavanisTsakonas1">[65]</xref>
###xml 425 429 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo2">[66]</xref>
###xml 650 654 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Bray1">[67]</xref>
###xml 1028 1035 1004 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g005">Fig. 5A</xref>
###xml 1059 1064 1035 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D279A</sup>
###xml 1140 1147 1116 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g005">Fig. 5B</xref>
###xml 1171 1175 1147 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 1215 1223 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 1275 1282 1247 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g005">Fig. 5B</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 1209 1214 <span type="species:ncbi:9606">human</span>
Our observation that overexpression of fly and human X11 does not alter gamma-secretase mediated cleavage of APP stands in contrast to a previous report [36]. To explore this issue further, we asked whether X11L overexpression could regulate gamma-cleavage of Notch, another substrate of gamma-secretase. Notch is a transmembrane receptor that mediates cell-cell communication events in multiple developmental contexts [65], [66]. Following cleavage of its extracellular domain (the S2 cleavage), Notch requires gamma-secretase-mediated cleavage (denoted S3) to release the Notch intracellular domain (NICD), and activate downstream signaling events [67]. To analyze Notch processing, a transmembrane version of Notch representing the S2 cleaved fragment was Myc-tagged at its C-terminus and specifically expressed in the fly eye. Silencing of any one of the four gamma-secretase components led to decreased gamma-cleavage of Notch, as demonstrated by decreased levels of NICD, and an increase in the levels of uncleaved Notch (Fig. 5A). Overexpression of PsnD279A also caused reduced levels of NICD and an accumulation of uncleaved Notch (Fig. 5B). In contrast, neither X11L overexpression nor expression of human X11alpha led to any significant effects on NICD production (Fig. 5B).
###end p 32
###begin title 33
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
X11L overexpression does not regulate the effect of gamma-secretase activity on Notch.
###end title 33
###begin p 34
###xml 351 355 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 365 373 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 461 463 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DN</sup>
###xml 550 565 538 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila X11L</italic>
###xml 579 587 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 659 662 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 359 364 <span type="species:ncbi:9606">human</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
(A-B) Western blotting of adult head lysates from various transgenic flies expressing the S2-cleaved Notch fragment (a gamma-secretase substrate). (A) Eye-specific silencing of any of the four component of the gamma-secretase complex results in a reduction of NICD levels and an increase in the levels of uncleaved Notch. (B) Overexpression of either X11L or human X11alpha fails to alter S2-cleaved Notch levels or NICD levels, in contrast to expression of PsnDN. (C-E) SEMs of adult fly eyes of various genotypes. Eye-specific expression of either Drosophila X11L (D) or human X11alpha (E) does not modify the eye phenotype due to eye-specific knockdown of psn (C). Insets show a close-up view of the ommatidia.
###end p 34
###begin p 35
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 148 152 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 157 160 153 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 197 200 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 235 238 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 282 289 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g005">Fig. 5C</xref>
###xml 363 368 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch</italic>
###xml 412 416 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Cagan1">[68]</xref>
###xml 449 452 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 523 526 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 551 556 547 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D279A</sup>
###xml 633 648 629 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila X11L</italic>
###xml 658 661 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 727 741 723 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g005">Fig. 5D and 5E</xref>
###xml 778 782 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 652 657 <span type="species:ncbi:9606">human</span>
To further test the hypothesis that overexpression of X11L does not affect gamma-secretase activity, we searched for a genetic interactions between X11L and psn in vivo. RNAi-mediated silencing of psn specifically in the eye (GMR-RNAi-psn) resulted in flies with small, rough eyes (Fig. 5C). This is likely due to impaired cleavage of Notch since partial loss of Notch function also results in small, rough eyes [68]. As expected, overexpression of psn partially suppressed the rough eye phenotype associated with GMR-RNAi-psn, while expression of PsnD279A enhanced this phenotype (data not shown). In contrast, expression of either Drosophila X11L or human X11 did not result in enhancement of the GMR-RNAi-psn eye phenotype (Fig. 5D and 5E), suggesting that overexpression of X11L does not significantly inhibit gamma-secretase activity in vivo.
###end p 35
###begin title 36
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
ubqn acts to stabilize the steady-state levels of APP
###end title 36
###begin p 37
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 683 690 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002495.s001">Fig. S1</xref>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 779 786 779 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6C</xref>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6B</xref>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 951 958 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6D</xref>
To study ubqn function in Drosophila, we generated two RNAi constructs targeted to two independent regions of ubqn (the coding region and the 3'-untranslated region, respectively), and used these transgenic flies to carry out tissue-specific silencing [47]. As described previously, ubiquitous expression of RNAi-ubqn resulted in a loss of detectable Ubqn protein [47]. Both ubqn RNAi transgenes silenced ubqn expression to similar levels and gave identical phenotypes in all experiments [47]. Using the same RNAi hairpins, we carried out eye-specific silencing of ubqn (GMR-RNAi-ubqn); effects confirmed by Western blotting of head lysates using anti-Ubqn antibodies (Supplementary Fig. S1). Though silencing of ubqn function did not lead to any overt developmental phenotypes (Fig. 6C), it strongly suppressed the GAMAREP phenotype (Fig. 6B compared with 6A). Importantly, silencing of ubqn did not alter the false positive reporter eye phenotypes (Fig. 6D compared with 2D), suggesting that the suppression of GAMAREP was specifically due to an effect on C99.
###end p 37
###begin title 38
Ubqn binds to APP via its UBA domain and modulates APP levels.
###end title 38
###begin p 39
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">grim</italic>
###xml 319 325 319 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">reaper</italic>
###xml 332 339 332 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g002">Fig. 2D</xref>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
(A-F) SEMs of adult fly eyes of various genotypes. Eye-specific ubqn knockdown by itself does not show any visible phenotypes (C). However, silencing of ubqn strongly suppresses the GAMAREP phenotypes (compare B to A). ubqn knockdown does not modify the eye phenotype of the false positive reporter (GMR-Gal4, UAS-grim/reaper) (see Fig. 2D). (D). Eye-specific silencing of ubqn modestly suppresses the eye phenotype of AICDREP (compare F to E). (G-I) Western blotting of adult head lysates. (G) Eye-specific silencing of ubqn leads to decreased levels of APP, CTFs and AICD. (H) ubqn knockdown results in decreased AICD-Myc levels. (I) Eye-specific overexpression of ubqn results in an increase in the levels of APP, the CTFs and AICD. A non-specific band (marked by an asterisk) serves as the loading control. (J) GST pulldown assay. The input lanes show C99 levels from 0.1 to 2.5% of the S2 cell lysates used for each pulldown. Compared with control (GST alone), Ubqn and UbqnDeltaUBL, but not UbqnDeltaUBA, binds to C99. In addition, Ubqn and UbqnDeltaUBL show similar binding to C99, as well as to higher molecular weight products that are likely polyubiquitinated forms of C99.
###end p 39
###begin p 40
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6G</xref>
###xml 385 392 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6G</xref>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 97 102 <span type="species:ncbi:9606">human</span>
We next investigated how ubqn loss-of-function suppressed GAMAREP. APP-Myc was co-expressed with human BACE in the eye. Silencing of ubqn resulted in a reduction of steady state levels of full length APP as well as its proteolytic fragments (C99, C83 and AICD) in the eye (Fig. 6G). Importantly, the reduction of full length APP and its cleaved forms occurred largely proportionately (Fig. 6G), suggesting that loss of ubqn leads to a decrease in the overall steady-state levels of APP, not a decrease in the activity of any particular secretase.
###end p 40
###begin p 41
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6F</xref>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6H</xref>
Since silencing of ubqn resulted in a decrease in AICD levels as a consequence of reduced APP levels, we asked if silencing ubqn would also affect the AICD reporter eye phenotypes. RNAi-ubqn flies were crossed to flies overexpressing Myc-tagged AICD. Indeed, we observed that eye-specific expression of RNAi-ubqn led to a modest suppression of the AICDREP (Fig. 6F compared with 6E), and a reduction in AICD levels in vivo (Fig. 6H).
###end p 41
###begin p 42
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 365 386 365 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002495.s001">Supplementary Fig. S1</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 473 480 473 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6I</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 734 741 726 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6I</xref>
###xml 831 835 823 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 927 931 919 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 1036 1040 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
To determine if ubqn acts as a dose-dependent regulator of APP levels, we examined the consequences of ubqn overexpression on APP levels. Eye-specific overexpression of ubqn (GMR-ubqn) did not generate any overt eye phenotypes, or suppress the GAMAREP eye phenotypes (data not shown). Expression levels of ubqn overexpression was confirmed by anti-Ubqn antibodies (Supplementary Fig. S1). However, ubqn overexpression (GMR-Gal4, UAS-ubqn) led to an increase in APP levels (Fig. 6I). As with silencing of ubqn, ubqn overexpression increased the steady state levels of the full length and gamma-secretase cleaved fragments of APP largely in proportion, suggesting that perturbation of Ubqn levels does not affect gamma-cleavage of APP (Fig. 6I). Together, we concluded that the suppression of the GAMAREP phenotype caused by loss of ubqn function is most likely the result of a decrease in APP steady-state levels. While loss of ubqn strongly suppressed the GAMAREP phenotype, we did not observe a significant enhancement of GAMAREP upon ubqn overexpression. This is most likely due to the fact that our GAMAREP reporter is much less sensitive in detecting enhancers than suppressors. This is based on multiple screens carried out to identify modifiers of GAMAREP, from which we isolated a dozen GAMAREP suppressors but no enhancers (unpublished observations).
###end p 42
###begin p 43
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6J</xref>
###xml 536 543 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6J</xref>
###xml 660 667 660 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002495-g006">Fig. 6J</xref>
How Ubqn regulates APP levels is unclear, but could involve direct interactions between these proteins. To explore this hypothesis, we asked if Ubqn can bind to APP directly. We mixed purified GST and GST-Ubqn fusion proteins with lysates from Schneider 2 (S2) cells transfected with Myc-tagged C99. Indeed, Myc-C99 specifically bound GST-Ubqn, but not GST alone (Fig. 6J). Interestingly, in addition to native-sized C99, GST-Ubqn preferentially bound to high molecular weight products, which are likely polyubiquitinated forms of C99 (Fig. 6J). Deletion of the UBA domain, but not the UBL domain, significantly abrogated the interaction between Ubqn and C99 (Fig. 6J), indicating that the UBA domain is required for this interaction.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
Here, we report the identification of two APP regulators, X11L and Ubqn, using a living reporter, GAMAREP. GAMAREP allows us to effectively identify regulators of gamma-secretase activity, APP steady-state levels and/or AICD function. Both the steady-state levels and the processing of APP have been demonstrated to be important in the pathogenesis of AD. However, the function of AICD, a much less studied APP fragment, may also be crucial for AD pathogenesis, since AICD is generated along with Abeta and may have functions including transcriptional regulation, signaling, apoptosis and calcium homeostasis. Importantly, when a protein regulates multiple aspects of APP, either directly or indirectly, the combination of GAMAREP, AICDREP, and our in vivo cleavage assays allows us to uncover the relative contributions of these regulatory inputs. This is of particular relevance in this study since both X11 and UBQLN1 have been proposed to have multiple functions affecting myriad pathways in various systems. Therefore, it is important to determine in vivo which pathways play predominant roles in events related to AD pathogenesis. Our data suggest that the predominant role of X11L is to regulate APP at the level of the AICD by a process requiring its PTB domain, whereas the major role of Ubqn is to regulate APP levels, likely through a direct physical interaction with APP that is dependent on the UBA domain of Ubqn.
###end p 45
###begin p 46
###xml 151 155 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 274 277 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 348 352 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-vonRotz1">[69]</xref>
###xml 455 459 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sumioka1">[70]</xref>
###xml 617 621 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
As a modifier of AICDREP, X11L does not regulate AICD levels. Following gamma-cleavage, AICD is thought to migrate into the nucleus. It is likely that X11L overexpression causes cytoplasmic retention of AICD based on the following observations. In mammalian cultured cells, X11 overexpression can reduce nuclear localization of the AICD with Tip60 [69]. Moreover, X11 can shuttle between the nucleus and cytoplasm to regulate AICD transcriptional targets [70]. Our functional studies using AICDREP suggest that the PTB domain of X11L is essential for X11's ability to regulate AICD. Therefore, our hypothesis is that X11L overexpression leads to the cytoplasmic retention of AICD via a direct physical interaction between the PTB domain of X11L and AICD.
###end p 46
###begin p 47
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King2">[36]</xref>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 135 145 131 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 215 219 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 246 250 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 424 427 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 594 597 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 613 617 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King2">[36]</xref>
###xml 894 897 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 1017 1021 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee2">[29]</xref>
###xml 1047 1050 1009 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 1182 1186 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Borg1">[25]</xref>
###xml 1188 1192 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Sastre1">[27]</xref>
###xml 1194 1198 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-King1">[33]</xref>
###xml 1200 1204 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Araki1">[34]</xref>
###xml 1266 1269 1228 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
We have also showed that, in contrast to prior studies [36], X11L overexpression does not inhibit gamma-secretase activity in vivo. In Drosophila, none of the APP cleavage products, C83, C99 or AICD, is affected by X11L overexpression. Moreover, X11L overexpression does not inhibit gamma-secretase activity in vivo towards another key substrate, Notch, at the level of cleavage, or at the level of genetic interaction with psn. In a prior study, King et al concluded that X11 inhibits gamma-secretase activity, based largely on the findings that extracellular Abeta levels were decreased upon X11 overexpression [36]. They interpreted this to be due to decreased Abeta production by gamma-secretase inhibition. However, decreased extracellular Abeta levels could also result from decreased Abeta secretion or increased Abeta degradation. In fact, another in vivo study suggested that although X11 overexpression led to reduced Abeta levels, levels of C83 and C99 (direct gamma-secretase substrates) did not increase [29]. Since overexpression of X11 can increase the steady-state levels of APP, likely by modulating APP trafficking to certain compartments in the secretory pathway [25], [27], [33], [34], an alternative interpretation of work by King et al is that X11 overexpression decreases Abeta via its modulation of APP trafficking, rather than by regulating gamma-secretase cleavage. Therefore, these prior studies are, in fact, consistent with our data and interpretation.
###end p 47
###begin p 48
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 331 335 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 357 361 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 616 620 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Zhang2">[50]</xref>
Our data also suggest that the predominant function of ubqn is to regulate APP levels, not gamma-secretase activity. We have established that Ubqn can bind to and stabilize APP. In contrast to the selective reduction of AICD and increase in CTFs seen following the knockdown of any one of the four gamma-secretase components, both ubqn loss-of-function and ubqn overexpression modify the levels of APP and its cleavage fragments largely in proportion. Our results are consistent with findings made by Zhang et al and different from Hiltunen et al; possible reasons for these differences are discussed in Zhang et al [50].
###end p 48
###begin p 49
###xml 117 121 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 125 129 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 185 189 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Li1">[48]</xref>
###xml 190 194 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Zhang2">[50]</xref>
###xml 269 272 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 354 364 350 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 364 368 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 534 538 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Loewer1">[71]</xref>
###xml 560 564 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 577 580 569 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 749 753 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 991 995 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Parks1">[72]</xref>
###xml 997 1001 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Vetrivel1">[73]</xref>
###xml 1034 1038 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 1099 1102 1071 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn</italic>
###xml 1201 1205 1169 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
In this study, we did not observe any alterations in gamma-secretase activity on APP in response to the silencing of ubqn or ubqn overexpression, similar to observations made by others [48]-[50]. However, we have previously shown that Ubqn binds to Psn and antagonizes psn function both during development and during adult-onset eye neurodegeneration in Drosophila[47]. There are several ways these observations can be reconciled. gamma-secretase activity is known to vary depending upon the substrate and the tissue in which it acts [71]. It is possible that ubqn antagonizes psn activity such that its effect on gamma-secretase is more evident on substrates other than APP in the eye. As a result, the modification of the gamma-cleavage of APP by ubqn, if any, might be below the detection limits of our assay. Alternatively, it is well established that in addition to being the catalytic core of the gamma-secretase complex, Psn can also function in a gamma-secretase independent fashion [72], [73]. Therefore, it is possible that ubqn primarily inhibits gamma-secretase independent functions of psn, leaving gamma-secretase dependent activity largely intact. In either case, the primary effect of ubqn on APP appears to be the regulation of APP steady state levels, and not inhibition of the gamma-cleavage of APP.
###end p 49
###begin p 50
###xml 345 349 342 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee1">[28]</xref>
###xml 351 355 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Lee2">[29]</xref>
###xml 679 689 672 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 689 693 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 329 344 <span type="species:ncbi:10090">transgenic mice</span>
###xml 579 584 <span type="species:ncbi:9606">human</span>
Here, using GAMAREP and AICDREP, in conjunction with in vivo cleavage analysis, we have identified factors that regulate APP. Further screens using these tools are likely to identify other proteins which may have implications for AD pathogenesis. Since increased expression of X11 attenuates Abeta production or secretion in APP transgenic mice [28], [29], but does not act on gamma-secretase directly (this work), X11 may present an attractive therapeutic target for AD. Similarly, since reduced Ubqn levels result in a modest decrease in APP levels, whereas expression of both human wildtype and the AD variant of UBQLN1 leads to adult onset, age-dependent eye degeneration in Drosophila[47], UBQLN1 may also be considered as a possible drug target for AD.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
Molecular Biology
###end title 52
###begin p 53
###xml 28 32 28 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Chen1">[74]</xref>
###xml 73 88 73 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psn, nct, aph-1</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pen-2</italic>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11L</italic>
###xml 385 394 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;,</italic>
###xml 406 414 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11&#945;</italic>
###xml 523 526 515 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X11</italic>
###xml 567 571 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ashley1">[75]</xref>
###xml 749 762 733 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 790 794 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 805 809 789 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 826 830 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 856 860 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 871 875 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 892 896 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubqn</italic>
###xml 900 904 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 1019 1022 1003 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sub>
###xml 1404 1408 1380 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubqn</italic>
###xml 1418 1422 1394 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ubqn</italic>
###xml 1458 1462 1430 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 379 384 <span type="species:ncbi:9606">human</span>
###xml 676 681 <span type="species:ncbi:9606">human</span>
###xml 749 762 <span type="species:ncbi:4932">S. cerevisiae</span>
A microRNA-based technology [74] was used for RNAi silencing. To silence psn, nct, aph-1 and pen-2, the respective coding regions were independently targeted. PCR products of these microRNA precursors were cloned into pGMR. To generate GMR-X11L and UAS-X11L, the X11L coding sequence was PCR amplified from the EST clone, LD29081, and subcloned into each vector. To generate GMR-human-X11alpha, a clone of X11alpha (kindly provided by Declan McLoughlin) was subcloned into the EcoR1 and Not1 sites of pGMR. To generate GMR-X11DeltaPTB, the insert of UAS-X11LDeltaPTB [75] was subcloned into pGMR vector. To generate GMR-AICD-Gal4, the nucleotide region encoding the predicted human AICD fragment was PCR amplified and fused in-frame, upstream of an S. cerevisiae Gal4 sequence. To make GMR-ubqn, GMR-RNAi-ubqnCDS and GMR-RNAi-ubqnUTR, the inserts from UAS-ubqn, UAS-RNAi-ubqnCDS and UAS-RNAi-ubqnUTR [47] were subcloned into pGMR vector, respectively. To generate pGMR-APP-9Myc and GMR-AICD-9Myc, coding sequence of APP695 or AICD was PCR amplified and cloned in-frame upstream of a 9xMyc sequences that has been previously subcloned into pGMR vector. C99-9Myc was also generated by PCR and subcloned to generate pMT-C99-9Myc and GMR-C99-9Myc, respectively. To make pGEX-UbqnDeltaUBL, a PCR fragment encoding UbqnDeltaUBL was subcloned into the EcoR1 and Not1 sites of the modified pGEX4T-1 vector. pGEX-Ubqn and pGEX-UbqnDeltaUBA, were described previously [47]. All cloned PCR products were confirmed by DNA sequencing.
###end p 53
###begin title 54
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
Drosophila Genetics and Strains
###end title 54
###begin p 55
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1118</sup>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w<sup>1118</sup></italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BACE</italic>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Greeve1">[60]</xref>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hid</italic>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Yoo1">[64]</xref>
###xml 616 621 616 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D257A</sup>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
For the X chromosome EP screen, individual lines of females carrying a single inserted EP element were individually crossed to GAMAREP males. Progeny carrying one copy of an EP insertion and one copy of GAMAREP were examined, and their eye size compared with control flies derived from a cross of w1118 females to GAMAREP males. For experiments involving transgenic flies, multiple independent fly lines were generated (Rainbow Transgenic Flies) and tested for each transgene. UAS-BACE flies [60] were obtained from Rita Reifegerste via Doris Kretzschmar, and UAS-hid flies [64] were obtained from Bruce Hay. GMR-PsnD257A was described previously [59].
###end p 55
###begin title 56
Scanning Electron Microscopy
###end title 56
###begin p 57
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Guo1">[59]</xref>
Freshly sacrificed flies were mounted on their side with one eye upward on white tape using clear nail polish. All flies were placed on a rotating platform to permit for orientation under vacuum and were imaged at 180x magnification and 100 psi using a Hitachi 2460N scanning electron microscope. Analysis of eye phenotypes was performed as described previously [59].
###end p 57
###begin title 58
Antibody Generation
###end title 58
###begin p 59
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 16 19 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 133 136 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 182 189 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 253 256 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
###xml 302 309 <span type="species:ncbi:9986">rabbits</span>
A fusion of GST-TEV to Drosophila X11L residues 452-775, corresponding to a region within the N-terminal domain, with an intervening TEV protease recognition site, was purified from E. coli lysates. Glutathione agarose-retained proteins were cleaved by TEV protease to remove GST, and used to immunize rabbits (Imgenex).
###end p 59
###begin title 60
Lysate Preparation and Western Blotting
###end title 60
###begin p 61
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
Heads from age and sex-matched adults were disrupted in lysis buffer, complete protease inhibitor cocktail (Roche) using a sonicator-3000 from MISONIX. Samples were sonicated. Samples were boiled, centrifuged, and total protein from 4 heads per genotype was analyzed by Western blotting. Antibodies used were anti-Myc (Upstate), anti-Ubqn [47], anti-X11L and anti-Tubulin (Sigma).
###end p 61
###begin title 62
S2 Cell Culture and Transfection
###end title 62
###begin p 63
###xml 35 45 35 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 260 261 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 557 558 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
S2 cells were grown in Schneider's Drosophila medium (Invitrogen) supplemented with 10% FBS, 50 units/ml penicillin, and 50 mug/ml streptomycin at room temperature. Transfections were carried out using MaxFect transfection reagent (Molecula). Typically, 1.5x106 cells plated in a 12-well dish were transfected with 0.7 - 1 mug total plasmid DNA plus 5 muL MaxFect reagent. Metallothionein promoter expression was induced with 0.5 mM copper sulfate 24 hours after transfection. S2 cell lysates were prepared by harvesting transfected cells (approximately5x106) in 1 mL lysis buffer, followed by incubation on ice for 10 minutes and centrifugation (16,000xg, 10 min) to pellet insoluble debris.
###end p 63
###begin title 64
GST Pulldown Assay
###end title 64
###begin p 65
###xml 292 296 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002495-Ganguly1">[47]</xref>
###xml 41 48 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
10 mug GST fusion proteins purified from E. coli lysates were retained on 15 muL glutathione beads, and mixed with 400 mug S2 cell lysate in 1mL total volume. Retained proteins were eluted by boiling in Laemmli sample buffer, and detected by Western blotting with anti-Myc antibody (Covance) [47].
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
The expression levels of X11L and ubqn transgenes. (A) We have generated polyclonal antibodies against X11L. X11L overexpression is accomplished using either an eye-specific promoter (GMR-X11L) or the eye-specific driver using the UAS-GAL4 system (GMR-Gal4, UAS-X11L). Western blots of lysates from fly heads overexpressing X11L or lysates from Schneider 2 cells overexpressing X11L (MT-X11L) reveal a band of predicted size using anti-X11L antibodies. (B) Western blots of lysates from fly heads expressing RNAi-ubqn or ubqn using anti-Ubqn antibodies. Silencing of ubqn significantly reduces Ubqn levels, while ubqn overexpression increases Ubqn levels. A non-specific band (*) serves as protein loading control.
###end p 67
###begin p 68
(1.06 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 89 94 <span type="species:ncbi:9606">human</span>
We thank Hao Zhao for generating several crucial transgenic flies, Declan McLoughlin for human X11alpha cDNA, Vivian Budnik X11LDeltaPTB DNA, Bruce Hay, Rita Reifegerste and Doris Kretzschmar for fly stocks and DNA, Larry Zipursky for allowing us to use his sonicator, B. Hay for comments on the manuscript, and the Guo lab members for discussions.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Alzheimer's disease: genes, proteins, and therapy.
###end article-title 72
###begin article-title 73
Reconstitution of gamma-secretase activity.
###end article-title 73
###begin article-title 74
The gamma-secretase complex: machinery for intramembrane proteolysis.
###end article-title 74
###begin article-title 75
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
###end article-title 75
###begin article-title 76
Candidate gene for the chromosome 1 familial Alzheimer's disease locus.
###end article-title 76
###begin article-title 77
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.
###end article-title 77
###begin article-title 78
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.
###end article-title 78
###begin article-title 79
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy.
###end article-title 79
###begin article-title 80
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.
###end article-title 80
###begin article-title 81
A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.
###end article-title 81
###begin article-title 82
Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.
###end article-title 82
###begin article-title 83
###xml 52 67 <span type="species:ncbi:10090">transgenic mice</span>
Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain.
###end article-title 83
###begin article-title 84
Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression.
###end article-title 84
###begin article-title 85
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.
###end article-title 85
###begin article-title 86
Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.
###end article-title 86
###begin article-title 87
Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD).
###end article-title 87
###begin article-title 88
The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.
###end article-title 88
###begin article-title 89
The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling.
###end article-title 89
###begin article-title 90
C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression.
###end article-title 90
###begin article-title 91
Amyloid precursor protein cytoplasmic domain antagonizes reelin neurite outgrowth inhibition of hippocampal neurons.
###end article-title 91
###begin article-title 92
Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content.
###end article-title 92
###begin article-title 93
The X11/Mint family of adaptor proteins.
###end article-title 93
###begin article-title 94
Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease.
###end article-title 94
###begin article-title 95
Cyclin-dependent kinase 5, Munc 18a and Munc 18-interacting protein 1/X11alpha protein upregulation in Alzheimer's disease.
###end article-title 95
###begin article-title 96
The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion.
###end article-title 96
###begin article-title 97
Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein.
###end article-title 97
###begin article-title 98
X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion.
###end article-title 98
###begin article-title 99
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice.
###end article-title 99
###begin article-title 100
###xml 120 135 <span type="species:ncbi:10090">transgenic mice</span>
The neuronal adaptor protein X11beta reduces amyloid beta protein levels and amyloid plaques formation in the brains of transgenic mice.
###end article-title 100
###begin article-title 101
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein.
###end article-title 101
###begin article-title 102
###xml 152 157 <span type="species:ncbi:4932">yeast</span>
The intracellular cytoplasmic domain of the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system.
###end article-title 102
###begin article-title 103
Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms.
###end article-title 103
###begin article-title 104
X11alpha modulates secretory and endocytic trafficking and metabolism of amyloid precursor protein: mutational analysis of the YENPTY sequence.
###end article-title 104
###begin article-title 105
Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta-protein precursor metabolism.
###end article-title 105
###begin article-title 106
X11 alpha and x11 beta interact with presenilin-1 via their PDZ domains.
###end article-title 106
###begin article-title 107
X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein.
###end article-title 107
###begin article-title 108
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.
###end article-title 108
###begin article-title 109
Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein.
###end article-title 109
###begin article-title 110
Results of a high-resolution genome screen of 437 Alzheimer's disease families.
###end article-title 110
###begin article-title 111
Full genome screen for Alzheimer disease: stage II analysis.
###end article-title 111
###begin article-title 112
Family-based association between Alzheimer's disease and variants in UBQLN1.
###end article-title 112
###begin article-title 113
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
###end article-title 113
###begin article-title 114
Lack of association between UBQLN1 and Alzheimer disease.
###end article-title 114
###begin article-title 115
Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.
###end article-title 115
###begin article-title 116
The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.
###end article-title 116
###begin article-title 117
Association study of the Ubiquilin gene with Alzheimer's disease.
###end article-title 117
###begin article-title 118
ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila.
###end article-title 118
###begin article-title 119
Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: In vivo interaction with early-onset Alzheimer disease genes.
###end article-title 119
###begin article-title 120
Ubiquilin 1 modulates amyloid precursor protein trafficking and abeta secretion.
###end article-title 120
###begin article-title 121
An AICD-based functional screen to identify APP metabolism regulators.
###end article-title 121
###begin article-title 122
Drosophila in the study of neurodegenerative disease.
###end article-title 122
###begin article-title 123
Drosophila models of neurodegenerative disease.
###end article-title 123
###begin article-title 124
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
###end article-title 124
###begin article-title 125
Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
###end article-title 125
###begin article-title 126
###xml 90 95 <span type="species:ncbi:9606">human</span>
Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor.
###end article-title 126
###begin article-title 127
Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex.
###end article-title 127
###begin article-title 128
The role of presenilin cofactors in the gamma-secretase complex.
###end article-title 128
###begin article-title 129
###xml 33 38 <span type="species:ncbi:9606">human</span>
Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype.
###end article-title 129
###begin article-title 130
A reporter for amyloid precursor protein gamma-secretase activity in Drosophila.
###end article-title 130
###begin article-title 131
Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila.
###end article-title 131
###begin article-title 132
Expression and characterization of the Drosophila X11-like/Mint protein during neural development.
###end article-title 132
###begin article-title 133
The genetics of cell death: approaches, insights and opportunities in Drosophila.
###end article-title 133
###begin article-title 134
Caspase-Dependent Cell Death in Drosophila.
###end article-title 134
###begin article-title 135
Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms.
###end article-title 135
###begin article-title 136
Notch signaling: cell fate control and signal integration in development.
###end article-title 136
###begin article-title 137
Control of daughter cell fates during asymmetric division: interaction of Numb and Notch.
###end article-title 137
###begin article-title 138
Notch signalling: a simple pathway becomes complex.
###end article-title 138
###begin article-title 139
Notch is required for successive cell decisions in the developing Drosophila retina.
###end article-title 139
###begin article-title 140
The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor.
###end article-title 140
###begin article-title 141
The X11L/X11beta/MINT2 and X11L2/X11gamma/MINT3 scaffold proteins shuttle between the nucleus and cytoplasm.
###end article-title 141
###begin article-title 142
Cell-type-specific processing of the amyloid precursor protein by Presenilin during Drosophila development.
###end article-title 142
###begin article-title 143
Presenilin diversifies its portfolio.
###end article-title 143
###begin article-title 144
Pathological and physiological functions of presenilins.
###end article-title 144
###begin article-title 145
A Synthetic Maternal-Effect Selfish Genetic Element Drives Population Replacement in Drosophila.
###end article-title 145
###begin article-title 146
Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint.
###end article-title 146
###begin article-title 147
The adaptor protein X11Lalpha/Dmint1 interacts with the PDZ-binding domain of the cell recognition protein Rst in Drosophila.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a UCLA Neurobehavioral Genetics training grant to R.M.R.F., as well as grants and funds from the National Institute of Health (RO1 and KO8), the Alfred P. Sloan Foundation, the Alzheimer's Association, the American Federation of Aging Foundation, the Larry L. Hillblom Foundation, the Glenn Family Foundation and the Ellison Medical Foundation to M.G.
###end p 149

